Claudia Cali

431 total citations
15 papers, 243 citations indexed

About

Claudia Cali is a scholar working on Hematology, Genetics and Emergency Medicine. According to data from OpenAlex, Claudia Cali has authored 15 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 11 papers in Genetics and 8 papers in Emergency Medicine. Recurrent topics in Claudia Cali's work include Acute Myeloid Leukemia Research (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Hematological disorders and diagnostics (8 papers). Claudia Cali is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Hematological disorders and diagnostics (8 papers). Claudia Cali collaborates with scholars based in Netherlands, Italy and United States. Claudia Cali's co-authors include Theresia M. Westers, Canan Alhan, Arjan A. van de Loosdrecht, Eline M.P. Cremers, Gert J. Ossenkoppele, Hideto Tamura, Cristina Picone, Hiroshi Handa, Paresh Vyas and Anna Porwit and has published in prestigious journals such as Blood, European Journal of Cancer and British Journal of Haematology.

In The Last Decade

Claudia Cali

10 papers receiving 239 citations

Peers

Claudia Cali

HEMAT

GENET

IMMUN

Peter Noellke Germany

Michelina Santopietro Italy

Carmen Sanzo Spain

H. Kreipe Germany

Adriano Salaroli Italy

Carlo Bodenizza Italy

Bernardine Favre France

Christiane Dobbelstein Germany

Caterina Stefanizzi Italy

JE Anderson United States

Peter Noellke Germany

Claudia Cali

128 ×0.5

HEMAT

56 ×0.5

GENET

36 ×0.5

40 ×0.9

GENET

37 ×0.9

IMMUN

Citations per year, relative to Claudia Cali Claudia Cali (= 1×) peers Peter Noellke

Countries citing papers authored by Claudia Cali

Since Specialization

Citations

This map shows the geographic impact of Claudia Cali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Cali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Cali more than expected).

Fields of papers citing papers by Claudia Cali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Cali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Cali. The network helps show where Claudia Cali may publish in the future.

Co-authorship network of co-authors of Claudia Cali

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Cali. A scholar is included among the top collaborators of Claudia Cali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Cali. Claudia Cali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Cremers, Eline M.P., Theresia M. Westers, Canan Alhan, et al.. (2016). Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes. Haematologica. 102(2). 320–326. 44 indexed citations

Cremers, Eline M.P., Theresia M. Westers, Canan Alhan, et al.. (2015). Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias. European Journal of Cancer. 54. 49–56. 24 indexed citations

Alhan, Canan, Theresia M. Westers, Eline M.P. Cremers, et al.. (2015). The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system. Leukemia. 30(3). 658–665. 27 indexed citations

Alhan, Canan, Theresia M. Westers, Eline M.P. Cremers, et al.. (2015). Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations. Cytometry Part B Clinical Cytometry. 90(4). 358–367. 14 indexed citations

Alhan, Canan, Theresia M. Westers, Eline M.P. Cremers, et al.. (2014). High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes. British Journal of Haematology. 167(1). 100–109. 18 indexed citations

Porta, Matteo Giovanni Della, Cristina Picone, Cristiana Pascutto, et al.. (2012). Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study. Haematologica. 97(8). 1209–1217. 110 indexed citations

Alhan, Canan, Theresia M. Westers, Eline M.P. Cremers, et al.. (2012). A Five Parameter Based Flow Cytometric Scoring System Refines the Revised International Prognostic Scoring System for Myelodysplastic Syndromes. Blood. 120(21). 3849–3849. 1 indexed citations

Picone, Cristina, Laura Vanelli, Luca Malcovati, et al.. (2011). MULTICENTRE VALIDATION OF A REPRODUCIBLE FLOW CYTOMETRIC SCORE FOR THE DIAGNOSIS OF LOWRISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A EUROPEAN LeukemiaNET STUDY. Cytometry Part A. 1051–1052. 1 indexed citations

Alhan, Canan, et al.. (2011). 287 Validation of a flow cytometric scoring system for the prognostication of the myelodysplastic syndromes; A retrospective cohort study. Leukemia Research. 35. S113–S113.

10.

Alhan, Canan, Corien Eeltink, Claudia Cali, et al.. (2011). 286 The presence of aberrant myeloid progenitors predicts overall survival in intermediate-2 and high risk myelodysplastic syndromes upon treatment with azacitidine. Leukemia Research. 35. S112–S112. 1 indexed citations

11.

Alhan, Canan, Theresia M. Westers, Corien Eeltink, et al.. (2010). Flow Cytometric Score Correlates with Clinical Response to Azacitidine In Intermediate-2 and High Risk Myelodysplastic Syndrome Patients. Blood. 116(21). 441–441. 1 indexed citations

12.

Westers, Theresia M., Canan Alhan, Monique Terwijn, et al.. (2009). C002 C-type lectin-like molecule-1 (CLL-1) and lineage infidelity marker expression as assessed by flow cytometry distinguishes normal and aberrant stem cells in myelodysplastic syndromes. Leukemia Research. 33. S31–S32. 2 indexed citations

13.

Alhan, Canan, et al.. (2009). P037 Apoptotic CD11bdimCD16pos neutrophil subpopulation represents a pitfall in pattern recognition of neutrophil differentiation by flow cytometry in myelodysplastic syndromes. Leukemia Research. 33. S79–S80.

14.

Westers, Theresia M., Monique Terwijn, Canan Alhan, et al.. (2008). Expression of C-Type Lectin-Like Molecule-1 (CLL-1) on Stem Cells Might Discriminate De Novo Acute Myeloid Leukemia from Acute Myeloid Leukemia Originating from Myelodysplastic Syndromes. Blood. 112(11). 2697–2697.

15.

Westers, Theresia M., Canan Alhan, Claudia Cali, Gert J. Ossenkoppele, & Arjan A. van de Loosdrecht. (2008). Quantitative Dynamics of Flow Cytometric Aberrancies during Treatment with Erythropoietin/G-CSF Are Predictive for Responses in LOW/INT-I Risk Myelodysplastic Syndromes.. Blood. 112(11). 1661–1661.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact